Chris Ottolenghi

7.7k total citations · 1 hit paper
106 papers, 4.8k citations indexed

About

Chris Ottolenghi is a scholar working on Molecular Biology, Clinical Biochemistry and Genetics. According to data from OpenAlex, Chris Ottolenghi has authored 106 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 36 papers in Clinical Biochemistry and 26 papers in Genetics. Recurrent topics in Chris Ottolenghi's work include Metabolism and Genetic Disorders (36 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (16 papers) and Sexual Differentiation and Disorders (12 papers). Chris Ottolenghi is often cited by papers focused on Metabolism and Genetic Disorders (36 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (16 papers) and Sexual Differentiation and Disorders (12 papers). Chris Ottolenghi collaborates with scholars based in France, Italy and United States. Chris Ottolenghi's co-authors include Antonino Forabosco, Manuela Uda, Laura Crisponi, Antonio Cao, David Schlessinger, Giuseppe Pilia, Ken McElreavey, Pascale de Lonlay, Shakib Omari and Anne‐Paule Gimenez‐Roqueplo and has published in prestigious journals such as Nature, Nature Medicine and Nature Communications.

In The Last Decade

Chris Ottolenghi

102 papers receiving 4.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma

2013 551 citations Éric Letouzé, Nelly Burnichon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Ottolenghi France	37	2.4k	1.5k	803	626	624	106	4.8k
Peter Igarashi United States	56	7.9k 3.3×	4.4k 2.9×	671 0.8×	1.5k 2.4×	583 0.9×	125	11.2k
Arun K. Roy United States	42	2.2k 0.9×	1.1k 0.7×	462 0.6×	408 0.7×	121 0.2×	127	5.0k
S. P. A. Toledo Brazil	44	2.4k 1.0×	852 0.6×	1.1k 1.4×	1.0k 1.7×	227 0.4×	159	6.7k
Fei Gao China	38	2.6k 1.1×	969 0.6×	497 0.6×	355 0.6×	1.1k 1.7×	134	4.6k
T. Mohandas United States	34	2.6k 1.1×	1.5k 1.0×	194 0.2×	281 0.4×	105 0.2×	65	3.9k
Ohad S. Birk Israel	33	2.1k 0.9×	1.2k 0.8×	142 0.2×	405 0.6×	206 0.3×	121	3.7k
Teruhisa Tsuzuki Japan	37	4.3k 1.8×	664 0.4×	977 1.2×	233 0.4×	170 0.3×	95	5.4k
Yvonne H. Edwards United Kingdom	39	4.5k 1.9×	1.1k 0.8×	304 0.4×	652 1.0×	137 0.2×	137	6.2k
Hideaki Bujo Japan	40	2.9k 1.2×	529 0.3×	793 1.0×	1.6k 2.6×	136 0.2×	186	6.5k
G I Bell United States	31	4.0k 1.7×	1.1k 0.7×	384 0.5×	1.4k 2.2×	107 0.2×	55	6.4k

Countries citing papers authored by Chris Ottolenghi

Since Specialization

Citations

This map shows the geographic impact of Chris Ottolenghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Ottolenghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Ottolenghi more than expected).

Fields of papers citing papers by Chris Ottolenghi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Ottolenghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Ottolenghi. The network helps show where Chris Ottolenghi may publish in the future.

Co-authorship network of co-authors of Chris Ottolenghi

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Ottolenghi. A scholar is included among the top collaborators of Chris Ottolenghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Ottolenghi. Chris Ottolenghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Narayanan, Ashwin, Arnaud Bruneel, Thierry Dupré, et al.. (2025). Nicotinamide metabolism reprogramming drives reversible senescence of glioblastoma cells. Cellular and Molecular Life Sciences. 82(1). 126–126.

Busiah, Kanetee, Célina Roda, Anaïs Brassier, et al.. (2024). Pubertal origin of growth retardation in inborn errors of protein metabolism: A longitudinal cohort study. Molecular Genetics and Metabolism. 141(3). 108123–108123. 1 indexed citations

Geoerger, Birgit, Manuel Schiff, Virginie Penard‐Lacronique, et al.. (2023). Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation. Nature Medicine. 29(6). 1358–1363. 5 indexed citations

Pontoizeau, Clément, Marion Benoist, Pasqualina Colella, et al.. (2023). Successful treatment of severe MSUD in Bckdhb^−/− mice with neonatal AAV gene therapy. Journal of Inherited Metabolic Disease. 47(1). 41–49. 4 indexed citations

Pontoizeau, Clément, Pasqualina Colella, M Girard, et al.. (2022). Neonatal gene therapy achieves sustained disease rescue of maple syrup urine disease in mice. Nature Communications. 13(1). 3278–3278. 14 indexed citations

Lonlay, Pascale de, Roland Posset, Ulrike Mütze, et al.. (2021). Real‐world management of maple syrup urine disease (MSUD) metabolic decompensations with branched chain amino acid‐free formulas in France and Germany: A retrospective observational study. JIMD Reports. 59(1). 110–119. 6 indexed citations

Buffet, Alexandre, Aurélie Morin, Luis-Jaime Castro-Vega, et al.. (2018). Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas. Cancer Research. 78(8). 1914–1922. 99 indexed citations

Weiss, Nicolas, Fanny Mochel, Marika Rudler, et al.. (2017). Peak hyperammonemia and atypical acute liver failure: The eruption of an urea cycle disorder during hyperemesis gravidarum. Journal of Hepatology. 68(1). 185–192. 23 indexed citations

Hardonnière, Kévin, Elise F. Saunier, Anthony Lemarié, et al.. (2016). The environmental carcinogen benzo[a]pyrene induces a Warburg-like metabolic reprogramming dependent on NHE1 and associated with cell survival. Scientific Reports. 6(1). 30776–30776. 55 indexed citations

10.

Brassier, Anaïs, Vassili Valayannopoulos, Nadia Bahi‐Buisson, et al.. (2015). Two new cases of serine deficiency disorders treated with l-serine. European Journal of Paediatric Neurology. 20(1). 53–60. 29 indexed citations

11.

Lussey‐Lepoutre, Charlotte, Constance Thibault, Alexandre Buffet, et al.. (2015). From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytoma. Molecular and Cellular Endocrinology. 421. 40–48. 31 indexed citations

12.

Gataullina, Svetlana, Georges Dellatolas, Hervé Perdry, et al.. (2012). Comorbidity and metabolic context are crucial factors determining neurological sequelae of hypoglycaemia. Developmental Medicine & Child Neurology. 54(11). 1012–1017. 18 indexed citations

13.

Brodin-Sartorius, Albane, Marie-Josèphe Tête, Patrick Niaudet, et al.. (2011). Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. Kidney International. 81(2). 179–189. 142 indexed citations

14.

Barth, Magalie, Chris Ottolenghi, Laurence Hubert, et al.. (2010). Multiple sources of metabolic disturbance inETHE1‐related ethylmalonic encephalopathy. Journal of Inherited Metabolic Disease. 33(S3). 443–453. 24 indexed citations

15.

Ottolenghi, Chris, Manuela Uda, Laura Crisponi, et al.. (2006). Determination and stability of sex. BioEssays. 29(1). 15–25. 43 indexed citations

16.

Herrera, Luisa, Chris Ottolenghi, José Elías García‐Ortíz, et al.. (2005). Mouse ovary developmental RNA and protein markers from gene expression profiling. Developmental Biology. 279(2). 271–290. 52 indexed citations

17.

Ottolenghi, Chris, Marc Fellous, Marcello Barbieri, & Ken McElreavey. (2002). Novel Paralogy Relations Among Human Chromosomes Support a Link between the Phylogeny of doublesex -Related Genes and the Evolution of Sex Determination. Genomics. 79(3). 333–343. 88 indexed citations

18.

Ottolenghi, Chris, Iraj Daizadeh, Σοφία Κοσσίδα, et al.. (2000). The genomic structure of C14orf1 is conserved across eukarya. Mammalian Genome. 11(9). 786–788. 5 indexed citations

19.

Ottolenghi, Chris, Reiner A. Veitia, Marcello Barbieri, Marc Fellous, & Ken McElreavey. (2000). The Human Doublesex-Related Gene, DMRT2, Is Homologous to a Gene Involved in Somitogenesis and Encodes a Potential Bicistronic Transcript. Genomics. 64(2). 179–186. 51 indexed citations

20.

Veitia, Reiner A., Anne Laurent, Lluís Quintana‐Murci, et al.. (1998). The INSL4 gene maps close to WI-5527 at 9p24.1→p23.3 clustered with two relaxin genes and outside the critical region for the monosomy 9p syndrome. Cytogenetic and Genome Research. 81(3-4). 275–277. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact